WallStreetZenWallStreetZen

NASDAQ: IAM
Iambic Therapeutics Inc Stock Ownership - Who owns Iambic Therapeutics?

OverviewEarningsRevenueDividendOwnership

Insider buying vs selling

Have Iambic Therapeutics Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when IAM insiders and whales buy or sell their stock.

IAM Shareholders

What type of owners hold Iambic Therapeutics Inc stock?

No data
There are no institutional or insider shareholders.

IAM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AARD0.04%46.39%Net SellingNet Selling
ABVC0.00%78.89%
ABVX0.07%0.00%
ACET0.04%99.96%Net Buying
TRXB0.00%37.74%Net BuyingNet Buying
View Top Biotech Stocks

Iambic Therapeutics Stock Ownership FAQ

Who owns Iambic Therapeutics?

Iambic Therapeutics (NASDAQ: IAM) is owned by 0.00% institutional shareholders, 7.58% Iambic Therapeutics insiders, and 92.42% retail investors.

If you're new to stock investing, here's how to buy Iambic Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.